Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citi Raises BHP Billiton And Rio Tinto To Buy

Fri, 10th Jul 2015 08:37

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
CITIGROUP RAISES BHP BILLITON TO 'BUY' ('NEUTRAL') - PRICE TARGET 1400 (1500) PENCE
----------
CITIGROUP RAISES RIO TINTO TO 'BUY' - PRICE TARGET 2800 (2950) PENCE
----------
CITIGROUP CUTS RANDGOLD RESOURCES PRICE TARGET TO 4644 (5228) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ANTOFAGASTA PRICE TARGET TO 600 (650) PENCE - 'SELL'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1090 (1125) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 287 (305) PENCE - 'BUY'
----------
EXANE BNP CUTS GKN PRICE TARGET TO 370 (380) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS GKN PRICE TARGET TO 355 (400) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1490 (1540) PENCE - 'HOLD'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1800 (1925) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES AB FOODS PRICE TARGET TO 3500 (3200) PENCE - 'OUTPERFORM'
----------
BERNSTEIN CUTS MARKS & SPENCER PRICE TARGET TO 535 (595) PENCE - MARKET-PERFORM
----------
BARCLAYS RAISES STANDARD LIFE PRICE TARGET TO 546 (520) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1148 (1106) PENCE - OVERWEIGHT
----------
BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 436 (428) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 289 (285) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES AVIVA PRICE TARGET TO 637 (632) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ADMIRAL GROUP PRICE TARGET TO 1572 (1523) PENCE - EQUAL WEIGHT
----------
BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 1889 (1877) PENCE - 'OVERWEIGHT'
----------
BERENBERG RAISES BAE SYSTEMS TO 'BUY' ('HOLD') - TARGET 570 (530) PENCE
----------
FTSE 250
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 285 (300) PENCE - 'HOLD'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 470 (480) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SPECTRIS PRICE TARGET TO 2415 (2500) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 200 (220) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS DRAX GROUP PRICE TARGET TO 270 (370) PENCE - 'HOLD'
----------
GOLDMAN CUTS DRAX GROUP PRICE TARGET TO 285 (411) PENCE - 'NEUTRAL'
----------
BERNSTEIN CUTS DRAX GROUP PRICE TARGET TO 370 (420) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS MELROSE PRICE TARGET TO 285 (310) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMI PRICE TARGET TO 1050 (1080) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 850 (800) PENCE - 'OUTPERFORM'
----------
SOCGEN CUTS IMI PRICE TARGET TO 1400 (1450) PENCE - 'BUY'
----------
PANMURE RAISES BREWIN DOLPHIN HLDGS PRICE TARGET TO 350 (300) PENCE - 'BUY'
----------
SOCGEN INITIATES CRODA WITH 'BUY' - TARGET 3050 PENCE
----------
CITIGROUP CUTS POLYMETAL PRICE TARGET TO 465 (522) PENCE - 'SELL'
----------
JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 265 (275) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 330 (343) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS PETRA DIAMONDS PRICE TARGET TO 180 (215) PENCE - 'BUY'
----------
JPMORGAN RAISES HAYS PRICE TARGET TO 155 (145) PENCE - 'NEUTRAL'
----------
UBS CUTS LONMIN TO 'SELL' ('NEUTRAL') - TARGET 75 (130) PENCE
----------
CITIGROUP CUTS LONMIN PRICE TARGET TO 113 (144) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS KAZ MINERALS PRICE TARGET TO 270 (300) PENCE - 'BUY'
----------
CITIGROUP RAISES ACACIA MINING PRICE TARGET TO 312 (283) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES DIGNITY PRICE TARGET TO 2260 (1850) PENCE - 'HOLD'
----------
UBS RAISES MICRO FOCUS PRICE TARGET TO 1460 (1420) PENCE - 'NEUTRAL'
----------
UBS RAISES HALFORDS GROUP PRICE TARGET TO 530 (485) PENCE - 'NEUTRAL'
----------
UBS RAISES DERWENT LONDON PRICE TARGET TO 3750 (3600) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES PHOENIX GROUP PRICE TARGET TO 794 (790) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 456 (463) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HISCOX PRICE TARGET TO 607 (620) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ESURE GROUP PRICE TARGET TO 300 (288) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS AMLIN PRICE TARGET TO 391 (407) PENCE - 'UNDERWEIGHT'
----------
SOCGEN CUTS ASHMORE GROUP PRICE TARGET TO 325 (350) PENCE - 'BUY'
----------
BERENBERG CUTS BALFOUR BEATTY PRICE TARGET TO 250 (260) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
CITIGROUP CUTS SOUTH32 PRICE TARGET TO 110 (140) PENCE - 'BUY'
----------
CITIGROUP RAISES PETROPAVLOVSK PRICE TARGET TO 6 (5) PENCE - 'SELL'
----------
CITIGROUP CUTS POLYUS GOLD PRICE TARGET TO 185 (194) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES HOCHSCHILD MINING PRICE TARGET TO 75 (65) PENCE - 'SELL'
----------
CITIGROUP CUTS GEM DIAMONDS PRICE TARGET TO 155 (161) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES FERREXPO PRICE TARGET TO 38 (31) PENCE - 'SELL'
----------
BARCLAYS RAISES PARTNERSHIP PRICE TARGET TO 117 (111) PENCE - 'UNDERWEIGHT'
----------
BERENBERG CUTS PENDRAGON PRICE TARGET TO 44 (45) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.